![\"\"](\"http:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/04\/EudraVigilance-4.29.jpg\")
<\/p>\n<\/p>\n
by\u00a0Brian Shilhavy
\nEditor, Health Impact News<\/p>\n
The European database of suspected drug reaction reports is\u00a0EudraVigilance,<\/a>\u00a0which also tracks reports of injuries and deaths following the experimental COVID-19 \u201cvaccines.\u201d<\/p>\n Here is what\u00a0EudraVigilance<\/a>\u00a0states about their database:<\/p>\n This website was launched by the\u00a0European Medicines Agency<\/a>\u00a0in 2012\u00a0to provide public access to reports of suspected side effects\u00a0<\/strong>(also known as suspected adverse drug reactions). These reports are submitted electronically to\u00a0EudraVigilance<\/a>\u00a0by national medicines regulatory authorities and by pharmaceutical companies that hold marketing authorisations (licences) for the medicines.<\/p>\n EudraVigilance is a system designed for collecting reports of suspected side effects. These reports are used for evaluating the benefits and risks of medicines during their development and monitoring their safety following their authorisation in the European Economic Area (EEA).\u00a0EudraVigilance has been in use since December 2001.<\/p>\n This website was launched to comply with the\u00a0EudraVigilance Access Policy<\/a>, which was developed to improve public health by supporting the monitoring of the safety of medicines and to increase transparency for stakeholders, including the general public.<\/p>\n The\u00a0Management Board of the European Medicines Agency<\/a>\u00a0first approved the EudraVigilance Access Policy in December 2010.\u00a0A revision was adopted by the Board in December 2015 based on the 2010 pharmacovigilance legislation.<\/span>\u00a0The policy aims to provide stakeholders such as national medicines regulatory authorities in the EEA, the European Commission, healthcare professionals, patients and consumers, as well as the pharmaceutical industry and research organisations, with access to reports on suspected side effects.<\/p>\n Transparency is a key guiding principle of the Agency, and is pivotal to building trust and confidence in the regulatory process. By increasing transparency, the Agency is better able to address the growing need among stakeholders, including the general public, for access to information. (Source<\/a>.)<\/p><\/blockquote>\n Their report through April 24, 2021 lists\u00a08,430 deaths and 354,177 injuries<\/strong>\u00a0following injections of four experimental COVID-19 shots:<\/p>\n A\u00a0Health Impact News<\/em>\u00a0subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. This subscriber has volunteered to do this, and it is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the\u00a0EudraVigilance<\/a>\u00a0system we have found that tabulates all the results.<\/p>\n Since we have started publishing this, others from Europe have also calculated the numbers and confirmed the totals.<\/p>\n Here is the summary data through April 24, 2021.<\/p>\n Total reactions<\/strong>\u00a0for the experimental mRNA vaccine\u00a0Tozinameran<\/strong>\u00a0(code\u00a0BNT162b2<\/strong>,Comirnaty<\/strong>) from\u00a0BioNTech<\/u><\/strong>\/\u00a0<\/u><\/strong>Pfizer:\u00a0<\/strong>4,524 deaths\u00a0<\/strong>and\u00a0151,306\u00a0<\/strong>injuries to 24\/04\/2021<\/p>\n Total reactions<\/strong>\u00a0for the experimental mRNA vaccine\u00a0mRNA-1273\u00a0<\/strong>(<\/strong>CX-024414)\u00a0<\/strong>from<\/strong>\u00a0Moderna:\u00a0<\/strong>2,283 death<\/strong>s\u00a0<\/strong>and\u00a017,625 injuries<\/strong>\u00a0to 24\/04\/2021<\/p>\n Total reactions<\/strong>\u00a0for the experimental\u00a0vaccine\u00a0<\/strong>AZD1222<\/strong>\u00a0<\/strong>(CHADOX1 NCOV-19)<\/strong>\u00a0from\u00a0<\/strong>Oxford<\/strong>\/<\/strong>\u00a0<\/strong>AstraZeneca<\/strong>:\u00a01,579 death<\/strong>s\u00a0<\/strong>and\u00a0184,833 injuries<\/strong>\u00a0to 24\/04\/2021<\/p>\n Total reactions<\/strong>\u00a0for the experimental\u00a0COVID-19 vaccine JANSSEN (AD26.COV2.S)\u00a0from\u00a0<\/strong>Johnson & Johnson<\/u><\/strong>:\u00a044 deaths\u00a0<\/strong>and\u00a0413 injuries<\/strong>\u00a0to 24\/04\/2021<\/p>\n This is public information funded by the European Medicines Agency (EMA), and anyone can use the\u00a0EudraVigilance<\/a>\u00a0system and verify this data.<\/p>\n Denmark<\/a>\u00a0and\u00a0Norway<\/a>\u00a0have completely suspended use of the AstraZeneca experimental COVID-19 shots.<\/p>\n A statement issued by the\u00a0Norwegian Institute of Public Health<\/a>\u00a0stated that the AstraZeneca COVID \u201cvaccine\u201d is more dangerous than COVID itself, especially for young people.<\/p>\n The EMA continues to recommend it. They did, however, add a safety warning to the J&J shots, due to fatal blood clots. (Source<\/a>.)<\/p>\n\n
\n
\n
\n
\n